SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Morgan Stanley Maintains Underweight on Allscripts Healthcare, Raises Price Target to $6

Morgan Stanley maintains Allscripts Healthcare (NASDAQ:MDRX) with a Underweight and raises the price target from $5 to $6.

Benzinga · 05/13/2020 15:44

Morgan Stanley maintains Allscripts Healthcare (NASDAQ:MDRX) with a Underweight and raises the price target from $5 to $6.